“…These findings align with results from other similar studies [2,5,8]. While recent reports discussing nAMD with BALAD are limited, existing literature indicates that, in almost all cases, ranibizumab, aflibercept, or bevacizumab rapidly resolved BALAD and significantly improved vision in most patients [2,5,[8][9][10]. Notably, most of these cases involved MNV type 2, similar to our patient's condition.…”